Cargando…
Mesenchymal Stem Cell (MSCs) Therapy for Ischemic Heart Disease: A Promising Frontier
Although tremendous progress has been made in conventional treatment for ischemic heart disease, it still remains a major cause of death and disability. Cell-based therapeutics holds an exciting frontier of research for complete cardiac recuperation. The capacity of diverse stem and progenitor cells...
Autores principales: | Poomani, Merlin Sobia, Mariappan, Iyyadurai, Perumal, Ramachandran, Regurajan, Rathika, Muthan, Krishnaveni, Subramanian, Venkatesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ubiquity Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916054/ https://www.ncbi.nlm.nih.gov/pubmed/35342702 http://dx.doi.org/10.5334/gh.1098 |
Ejemplares similares
-
Draft Genome Sequence of Bacillus pacificus KVCMST-8A-12, Isolated from a Marine Sediment Sample from the Kanyakumari Coast, India
por: Santhi, Asha, et al.
Publicado: (2021) -
Emerging role of mesenchymal stem/stromal cells (MSCs) and MSCs-derived exosomes in bone- and joint-associated musculoskeletal disorders: a new frontier
por: Gerami, Mohammad Hadi, et al.
Publicado: (2023) -
Neovascularization: The Main Mechanism of MSCs in Ischemic Heart Disease Therapy
por: Shi, Weili, et al.
Publicado: (2021) -
The promising approach of MSCs therapy for COVID-19 treatment
por: Samanipour, Reza, et al.
Publicado: (2022) -
Embryonic Stem Cell‐Derived Mesenchymal Stem Cells (MSCs) Have a Superior Neuroprotective Capacity Over Fetal MSCs in the Hypoxic‐Ischemic Mouse Brain
por: Hawkins, Kate E., et al.
Publicado: (2018)